Concepts (96)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA, Small Interfering | 5 | 2017 | 436 | 1.560 |
Why?
|
| Nanoparticles | 6 | 2020 | 460 | 1.070 |
Why?
|
| Gene Silencing | 3 | 2017 | 154 | 0.960 |
Why?
|
| Liposomes | 6 | 2020 | 132 | 0.830 |
Why?
|
| Drug Delivery Systems | 2 | 2020 | 277 | 0.650 |
Why?
|
| Antibiotics, Antineoplastic | 1 | 2020 | 51 | 0.640 |
Why?
|
| Doxorubicin | 1 | 2020 | 97 | 0.620 |
Why?
|
| Osteosarcoma | 1 | 2017 | 30 | 0.520 |
Why?
|
| Breast Neoplasms | 2 | 2020 | 1723 | 0.510 |
Why?
|
| Bone Neoplasms | 1 | 2017 | 49 | 0.510 |
Why?
|
| Aptamers, Nucleotide | 1 | 2017 | 51 | 0.490 |
Why?
|
| Tumor Suppressor Protein p53 | 1 | 2017 | 220 | 0.450 |
Why?
|
| Lipids | 3 | 2013 | 256 | 0.390 |
Why?
|
| Tissue Engineering | 2 | 2011 | 75 | 0.380 |
Why?
|
| Freeze Drying | 1 | 2011 | 29 | 0.360 |
Why?
|
| RNA Stability | 1 | 2011 | 28 | 0.360 |
Why?
|
| Liver | 2 | 2012 | 511 | 0.360 |
Why?
|
| Cell Line, Tumor | 6 | 2020 | 2676 | 0.340 |
Why?
|
| Urology | 1 | 2011 | 9 | 0.340 |
Why?
|
| Polyesters | 1 | 2011 | 28 | 0.340 |
Why?
|
| RNA Interference | 1 | 2011 | 247 | 0.330 |
Why?
|
| Nanocapsules | 1 | 2010 | 19 | 0.330 |
Why?
|
| Chemistry, Pharmaceutical | 1 | 2010 | 97 | 0.320 |
Why?
|
| Genetic Vectors | 1 | 2010 | 165 | 0.320 |
Why?
|
| Biocompatible Materials | 1 | 2011 | 108 | 0.310 |
Why?
|
| Antineoplastic Agents | 1 | 2017 | 1019 | 0.280 |
Why?
|
| Transfection | 4 | 2013 | 532 | 0.270 |
Why?
|
| Hepacivirus | 3 | 2012 | 74 | 0.260 |
Why?
|
| DNA | 1 | 2010 | 592 | 0.260 |
Why?
|
| Vitronectin | 1 | 2006 | 2 | 0.250 |
Why?
|
| Collagen Type I | 1 | 2006 | 35 | 0.250 |
Why?
|
| Osteoblasts | 1 | 2006 | 44 | 0.240 |
Why?
|
| Osteogenesis | 1 | 2006 | 57 | 0.240 |
Why?
|
| Mesenchymal Stem Cells | 1 | 2006 | 72 | 0.240 |
Why?
|
| Cell Culture Techniques | 3 | 2011 | 152 | 0.220 |
Why?
|
| Antibodies, Neutralizing | 1 | 2025 | 127 | 0.210 |
Why?
|
| Immunoglobulin G | 1 | 2025 | 259 | 0.210 |
Why?
|
| Particle Size | 2 | 2017 | 272 | 0.200 |
Why?
|
| Antibodies, Viral | 1 | 2025 | 306 | 0.190 |
Why?
|
| Protamines | 2 | 2011 | 21 | 0.170 |
Why?
|
| Cell Survival | 2 | 2017 | 945 | 0.170 |
Why?
|
| Hepatitis C | 2 | 2012 | 139 | 0.160 |
Why?
|
| Polyethylene Glycols | 1 | 2020 | 108 | 0.160 |
Why?
|
| Humans | 9 | 2025 | 43102 | 0.150 |
Why?
|
| Excipients | 1 | 2017 | 25 | 0.130 |
Why?
|
| Tumor Cells, Cultured | 1 | 2017 | 508 | 0.120 |
Why?
|
| Biology | 1 | 2016 | 20 | 0.120 |
Why?
|
| Models, Educational | 1 | 2016 | 46 | 0.120 |
Why?
|
| Fatty Acids, Monounsaturated | 2 | 2012 | 20 | 0.110 |
Why?
|
| Quaternary Ammonium Compounds | 2 | 2012 | 33 | 0.110 |
Why?
|
| Educational Measurement | 1 | 2016 | 102 | 0.110 |
Why?
|
| Cells, Cultured | 2 | 2011 | 1621 | 0.110 |
Why?
|
| Cholesterol | 2 | 2012 | 232 | 0.100 |
Why?
|
| Plasmids | 2 | 2013 | 244 | 0.100 |
Why?
|
| Virus Replication | 2 | 2012 | 318 | 0.090 |
Why?
|
| Mutation | 1 | 2017 | 1177 | 0.090 |
Why?
|
| Erythrocytes | 1 | 2013 | 126 | 0.090 |
Why?
|
| Female | 4 | 2025 | 24698 | 0.090 |
Why?
|
| Sonication | 1 | 2011 | 14 | 0.090 |
Why?
|
| Malaria, Falciparum | 1 | 2013 | 90 | 0.090 |
Why?
|
| Interferon-alpha | 1 | 2011 | 43 | 0.090 |
Why?
|
| Drug Resistance, Viral | 1 | 2011 | 67 | 0.090 |
Why?
|
| Plasmodium falciparum | 1 | 2013 | 144 | 0.090 |
Why?
|
| Hepatocytes | 1 | 2011 | 80 | 0.090 |
Why?
|
| Urothelium | 1 | 2011 | 8 | 0.090 |
Why?
|
| Nucleic Acid Conformation | 1 | 2011 | 154 | 0.080 |
Why?
|
| RNA, Viral | 1 | 2012 | 321 | 0.080 |
Why?
|
| Pressure | 1 | 2010 | 50 | 0.080 |
Why?
|
| Minority Groups | 1 | 2016 | 690 | 0.080 |
Why?
|
| Gene Transfer Techniques | 1 | 2010 | 53 | 0.080 |
Why?
|
| Animals | 3 | 2020 | 16992 | 0.080 |
Why?
|
| Nanotechnology | 1 | 2011 | 176 | 0.080 |
Why?
|
| Students | 1 | 2016 | 626 | 0.080 |
Why?
|
| Antiviral Agents | 1 | 2011 | 195 | 0.080 |
Why?
|
| Time Factors | 1 | 2011 | 1857 | 0.060 |
Why?
|
| Integrins | 1 | 2006 | 54 | 0.060 |
Why?
|
| Adsorption | 1 | 2006 | 74 | 0.060 |
Why?
|
| Extracellular Matrix | 1 | 2006 | 131 | 0.060 |
Why?
|
| Cell Adhesion | 1 | 2006 | 238 | 0.060 |
Why?
|
| Internet | 1 | 2025 | 236 | 0.050 |
Why?
|
| Cell Differentiation | 1 | 2006 | 638 | 0.050 |
Why?
|
| Mice | 2 | 2012 | 6644 | 0.050 |
Why?
|
| Data Mining | 1 | 2016 | 30 | 0.030 |
Why?
|
| Risk | 1 | 2016 | 287 | 0.030 |
Why?
|
| Regression Analysis | 1 | 2016 | 490 | 0.030 |
Why?
|
| DNA, Circular | 1 | 2013 | 8 | 0.020 |
Why?
|
| Curriculum | 1 | 2016 | 318 | 0.020 |
Why?
|
| Replicon | 1 | 2012 | 7 | 0.020 |
Why?
|
| Neoplasm Transplantation | 1 | 2012 | 129 | 0.020 |
Why?
|
| 5' Untranslated Regions | 1 | 2012 | 22 | 0.020 |
Why?
|
| Green Fluorescent Proteins | 1 | 2013 | 209 | 0.020 |
Why?
|
| Male | 2 | 2025 | 23409 | 0.020 |
Why?
|
| Nanostructures | 1 | 2013 | 161 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2012 | 694 | 0.020 |
Why?
|
| Middle Aged | 1 | 2025 | 12222 | 0.020 |
Why?
|
| Adult | 1 | 2025 | 13872 | 0.020 |
Why?
|